News & Opinion
Top 10 Innovations
Cell & Molecular Biology
Disease & Medicine
Ecology & Environment
Genetics & Genomics
Pharma & Biotech
Image of the Day
Pfizer to Halt Alzheimer’s and Parkinson’s Drug Research
Jim Daley | Jan 7, 2018
The company’s recent effort to find new treatments for Alzheimer’s ended in disappointment.
Dengue Vaccine Program Halted Over Safety Issues
Shawna Williams | Dec 5, 2017
The drug may worsen future infections for people who haven't already been exposed to the virus.
Clinical Trial Reporting for Pharma-Sponsored Trials Shows Improvement
Diana Kwon | Dec 4, 2017
The Good Pharma Scorecard finds some big pharmaceutical companies are meeting legal standards for disclosing results—but many studies still go unreported.
Study: Hidden Conflicts of Interest Permeate Medicine
Diana Kwon | Jan 18, 2017
Three investigations reveal the influence of industry money in patient advocacy groups, treatment guidelines, and Twitter feeds.
Novartis Buys US Drugmaker for Up To $665 Million
Tracy Vence | Nov 22, 2016
The Swiss pharma giant is acquiring Oklahoma-based Selexys Pharmaceuticals, a maker of drugs for inflammatory and thrombotic diseases.
The Growth of Iowa Biotech
Jenny Rood | Jul 31, 2016
The state’s industry draws inspiration from medicine as well as agriculture.
$1.5 Billion Pharma Buyout for Leukemia Drug
Jef Akst | Jun 1, 2016
Jazz Pharmaceuticals is set to purchase Celator to acquire an experimental treatment for acute myeloid leukemia.
Shire Buys Rare Disease Drug Developer
Tracy Vence | Nov 2, 2015
The Irish drugmaker is set to acquire the Massachusetts-based Dyax in a $5.9 billion deal.
Tracy Vence | Oct 22, 2015
A specialty pharmaceuticals company announces plans to produce a toxoplasmosis drug containing the same active ingredient as the pill at the center of an ongoing drug-pricing controversy.
Biotech Stocks Take a Hit
Kerry Grens | Sep 30, 2015
Some say the biotech bubble has burst over concerns that drug prices are too high—and may soon be regulated.